$9.19
-0.20[-2.13%]
At close: Apr 26
$9.19
0[0.00%]
After Hours: 4:16PM EDT
Adverum Biotechnologies
(NASDAQ:ADVM)Adverum Biotechnologies Stock (NASDAQ:ADVM), Quotes and News Summary
Adverum Biotechnologies Stock (NASDAQ: ADVM) stock price, news, charts, stock research, profile.
| Open | $9.600 |
| Close | $9.190 |
| Volume / Avg. | 798.696K / 294.287K |
| Day Range | 9.110 - 10.100 |
| 52 Wk Range | 7.100 - 29.700 |
| Market Cap | $190.738M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 20 |
| Short Interest | 4.46% |
| Days to Cover | 2.78 |
Recent News
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Adverum Biotechnologies Inc
Sector
Health Care
Industry
Biotechnology
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene th...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Adverum Biotechnologies (ADVM) stock?
You can purchase shares of Adverum Biotechnologies (NASDAQ: ADVM) through any online brokerage.
Who are Adverum Biotechnologies's (ADVM) competitors?
Other companies in Adverum Biotechnologies’s space includes: Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT), bluebird bio (NASDAQ:BLUE) and Atossa Therapeutics (NASDAQ:ATOS).
What is the target price for Adverum Biotechnologies (ADVM) stock?
The latest price target for Adverum Biotechnologies (NASDAQ: ADVM) was reported by Chardan Capital on Tuesday, March 19, 2024. The analyst firm set a price target for 4.00 expecting ADVM to fall to within 12 months (a possible -56.47% downside). 6 analyst firms have reported ratings in the last year.
Current Stock Price for Adverum Biotechnologies (ADVM)?
The stock price for Adverum Biotechnologies (NASDAQ: ADVM) is $9.19 last updated April 26, 2024 at 4:16 PM EDT.
Does Adverum Biotechnologies (ADVM) pay a dividend?
There are no upcoming dividends for Adverum Biotechnologies.
When is Adverum Biotechnologies (NASDAQ:ADVM) reporting earnings?
Adverum Biotechnologies’s Q1 earnings are confirmed for Thursday, May 9, 2024.
Is Adverum Biotechnologies (ADVM) going to split?
There is no upcoming split for Adverum Biotechnologies.
What sector and industry does Adverum Biotechnologies (ADVM) operate in?
Adverum Biotechnologies is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.